Lung Cancer, Small Cell
An adherent subline of a unique small cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule
8
An immunohistochemical study of cyclin dependent kinase 5 (CDK5) expression in non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
8
Safety and Efficacy of Racotumomab Alum Vaccine as Second Line Therapy for Advanced Non Small Cell Lung Cancer
8
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
6
Prognostic value of angiopoietin 2 in non small cell lung cancer patients: a meta analysis
9
Surgical treatment in non small cell lung cancer with pulmonary oligometastasis
5
Combination Chemotherapy for Small Cell Lung Cancer
5
Prognostic value of metformin for non small cell lung cancer patients with diabetes
5
Markers of small cell lung cancer
5
Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
8
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer
12
A Brief Review on Lung Cancer
8
Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report
6
Original Article The identification of genes associated with NSCLC prognosis based on an integrated bioinformatics analysis
8
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
5
In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration, inflammation and decreased adhesion
13
The roles of metallothioneins in carcinogenesis
20
Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment
8
Case Report Parotid gland and cerebellum metastasis of lung cancer: a case report
7
Pathological transition as the arising mechanism for drug resistance in lung cancer
13